Felix L.
- Country
- France
- Department
- Oncologie Médicale
Research Overview
Data & Insights
Has run more than one trial at 21 of 139 partner sites.
Specializations
Oncological Focus
This investigator specializes in treating advanced urological cancers, with particular emphasis on metastatic renal cell carcinoma (mRCC) and prostate cancer.
- Advanced kidney cancer management
- Prostate cancer with high-risk features
- Metastatic disease treatment
Their clinical interests extend to the application of innovative therapeutic approaches in urological oncology.
Treatment Modalities
The investigator focuses on integrating various treatment approaches, including immune checkpoint inhibitor combinations and targeted therapies.
- Immunotherapy combinations
- Radiation therapy optimization
- Hormone therapy applications
Their work encompasses both systemic treatments and localized therapeutic interventions.
Diagnostic Expertise
The investigator utilizes advanced diagnostic methodologies, including next-generation imaging and molecular biomarker analysis.
- PSMA PET/CT evaluation
- PDL1 stratification
- Risk classification assessment
Their approach incorporates precision diagnostics for treatment optimization.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.